Investor Relations


We are focused on the acquisition, development and commercialization of branded prescription products for specialty physician market segments. We have both product development and commercial capabilities and leverage our existing infrastructure to support growth. We aim to maximize the potential of our existing brands, while continuing to build a portfolio of differentiated products. We believe we have significant growth opportunities with our diversified product portfolio and continue to identify and pursue other promising product candidates.

Data Provided by Refinitiv. Minimum 15 minutes delayed.